HOSPITAL UNIVERSITARIO RUBER
Departamento
Hannover Medical School
Hanóver, AlemaniaPublicaciones en colaboración con investigadores/as de Hannover Medical School (4)
2021
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
-
Pharmacokinetic study (phase I−II) of a new dobutamine formulation in preterm infants immediately after birth
Pediatric Research, Vol. 89, Núm. 4, pp. 981-986
2019
-
Validity of biomarkers of early circulatory impairment to predict outcome: A retrospective analysis
Frontiers in Pediatrics, Vol. 7, Núm. MAY
2018
-
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer
Investigational New Drugs, Vol. 36, Núm. 5, pp. 848-859